Mitochondrially localised MUL1 is a novel modulator of antiviral signaling
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mitochondrially localised MUL1 is a novel modulator of antiviral signaling
Authors
Keywords
-
Journal
IMMUNOLOGY AND CELL BIOLOGY
Volume 91, Issue 4, Pages 321-330
Publisher
Wiley
Online
2013-02-12
DOI
10.1038/icb.2013.7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NLRX1 Protein Attenuates Inflammatory Responses to Infection by Interfering with the RIG-I-MAVS and TRAF6-NF-κB Signaling Pathways
- (2011) Irving C. Allen et al. IMMUNITY
- Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus
- (2011) S. M. Horner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial Membrane Potential Is Required for MAVS-Mediated Antiviral Signaling
- (2011) T. Koshiba et al. Science Signaling
- SUMO and ubiquitin paths converge
- (2010) Amanda Denuc et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Peroxisomes Are Signaling Platforms for Antiviral Innate Immunity
- (2010) Evelyn Dixit et al. CELL
- Reconstitution of the RIG-I Pathway Reveals a Signaling Role of Unanchored Polyubiquitin Chains in Innate Immunity
- (2010) Wenwen Zeng et al. CELL
- Virus-Infection or 5′ppp-RNA Activates Antiviral Signal through Redistribution of IPS-1 Mediated by MFN1
- (2010) Kazuhide Onoguchi et al. PLoS Pathogens
- Transforming Growth Factor-β Enhances Rhinovirus Infection by Diminishing Early Innate Responses
- (2009) Belinda J. Thomas et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes
- (2009) S-C Sun CELL DEATH AND DIFFERENTIATION
- Influenza A Virus NS1 Targets the Ubiquitin Ligase TRIM25 to Evade Recognition by the Host Viral RNA Sensor RIG-I
- (2009) Michaela Ulrike Gack et al. Cell Host & Microbe
- Mitochondrial dynamics regulate the RIG-I-like receptor antiviral pathway
- (2009) Céline Castanier et al. EMBO REPORTS
- MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission
- (2009) Emélie Braschi et al. EMBO REPORTS
- MyD88 Adapter-like (Mal)/TIRAP Interaction with TRAF6 Is Critical for TLR2- and TLR4-mediated NF-κB Proinflammatory Responses
- (2009) Brett Verstak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An additional role for SUMO in ubiquitin-mediated proteolysis
- (2009) Marie-Claude Geoffroy et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mitofusin 2 Inhibits Mitochondrial Antiviral Signaling
- (2009) K. Yasukawa et al. Science Signaling
- The E3 Ubiquitin Ligase Triad3A Negatively Regulates the RIG-I/MAVS Signaling Pathway by Targeting TRAF3 for Degradation
- (2009) Peyman Nakhaei et al. PLoS Pathogens
- GIDE is a mitochondrial E3 ubiquitin ligase that induces apoptosis and slows growth
- (2008) Bicheng Zhang et al. CELL RESEARCH
- Cargo-Selected Transport from the Mitochondria to Peroxisomes Is Mediated by Vesicular Carriers
- (2008) Margaret Neuspiel et al. CURRENT BIOLOGY
- Negative regulation of cytoplasmic RNA-mediated antiviral signaling
- (2008) Akihiko Komuro et al. CYTOKINE
- The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response
- (2008) Constantin S Friedman et al. EMBO REPORTS
- MAVS Dimer Is a Crucial Signaling Component of Innate Immunity and the Target of Hepatitis C Virus NS3/4A Protease
- (2008) M. Baril et al. JOURNAL OF VIROLOGY
- NLRX1 is a regulator of mitochondrial antiviral immunity
- (2008) Chris B. Moore et al. NATURE
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
- (2008) Hiroki Ishikawa et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started